IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Associates IX, LLC

Q4 2017 Holdings

Filed 2018-02-05 | 4 holdings | $112.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Intellia Therapeutics Inc(NTLA)COM45826J105$68.8K3,579,78860.9%
Synlogic IncCOM87166L100$25.7K2,651,96322.8%
Spero Therapeutics Inc(SPRO)COM84833T103$16.2K1,376,96814.3%
Snap Inc(SNAP)CL A83304A106$2.2K150,1601.9%